Sampatakakis Stefanos N, Roma Maria, Scarmeas Nikolaos
1st Department of Neurology, Aiginition Hospital, Athens Medical School, National and Kapodistrian University, 11528 Athens, Greece.
Department of Neurology, The Gertrude H. Sergievsky Center, Taub Institute for Research in Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY 10027, USA.
Curr Issues Mol Biol. 2024 Mar 2;46(3):1975-1986. doi: 10.3390/cimb46030129.
Subjective cognitive decline (SCD) has been described as a probable early stage of dementia, as it has consistently appeared to precede the onset of objective cognitive impairment. SCD is related to many risk factors, including genetic predisposition for dementia. The Apolipoprotein (APOE) ε4 allele, which has been thoroughly studied, seems to explain genetic risk for SCD only partially. Therefore, we aimed to summarize existing data regarding genetic factors related to SCD, beyond APOE ε4, in order to improve our current understanding of SCD. We conducted a PRISMA systematic search in PubMed/MEDLINE and Embase databases using the keywords "subjective cognitive decline" and "genetic predisposition" with specific inclusion and exclusion criteria. From the 270 articles identified, 16 were finally included for the qualitative analysis. Family history of Alzheimer's disease (AD) in regard to SCD was explored in eight studies, with conflicting results. Other genes implicated in SCD, beyond APOE ε4, were investigated in six studies, which were not strong enough to provide clear conclusions. Very few data have been published regarding the association of polygenic risk for AD and SCD. Thus, many more genes related to AD must be studied, with polygenic risk scores appearing to be really promising for future investigation.
主观认知衰退(SCD)被描述为痴呆症可能的早期阶段,因为它似乎始终先于客观认知障碍的出现。SCD与许多风险因素相关,包括痴呆症的遗传易感性。经过充分研究的载脂蛋白(APOE)ε4等位基因似乎只能部分解释SCD的遗传风险。因此,我们旨在总结除APOE ε4之外与SCD相关的遗传因素的现有数据,以增进我们目前对SCD的理解。我们使用关键词“主观认知衰退”和“遗传易感性”,并设定了特定的纳入和排除标准,在PubMed/MEDLINE和Embase数据库中进行了PRISMA系统检索。从识别出的270篇文章中,最终纳入16篇进行定性分析。八项研究探讨了阿尔茨海默病(AD)家族史与SCD的关系,结果相互矛盾。六项研究调查了除APOE ε4之外其他与SCD相关的基因,但这些研究的力度不足以得出明确结论。关于AD的多基因风险与SCD关联的已发表数据非常少。因此,必须研究更多与AD相关的基因,多基因风险评分似乎对未来的研究很有前景。